{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:49:08Z","timestamp":1783522148836,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010120","name":"Huashan Hospital Fudan University","doi-asserted-by":"publisher","award":["2022ZD0211600"],"award-info":[{"award-number":["2022ZD0211600"]}],"id":[{"id":"10.13039\/501100010120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pnpbp.2025.111282","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T16:05:33Z","timestamp":1739030733000},"page":"111282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Genetic insights of lipid metabolism and lipid-lowering drugs with Lewy body dementia risk: Evidence from Mendelian randomization"],"prefix":"10.1016","volume":"137","author":[{"given":"Hanyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111282_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2015.02.016","article-title":"Hypercholesterolemia in elders is associated with slower cognitive decline: a prospective, population-based study (NEDICES)","volume":"350","author":"Benito-Le\u00f3n","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111282_bb0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111282_bb0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111282_bb0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111282_bb0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111282_bb0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111282_bb0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.pnpbp.2025.111282_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204481","article-title":"Cholesterol levels, hormone replacement therapy, and incident dementia among older adult women","volume":"15","author":"Chiu","year":"2023","journal-title":"Nutrients"},{"issue":"19","key":"10.1016\/j.pnpbp.2025.111282_bb0050","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force","volume":"316","author":"Chou","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0055","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1038\/s41598-018-24248-8","article-title":"Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis","volume":"8","author":"Chu","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111282_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111282_bb0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-215295","article-title":"Plasma cholesterol levels as potential nutritional biomarkers for Lewy body dementia","volume":"86","author":"Dou","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2025.111282_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.788695","article-title":"Lipid metabolism influence on neurodegenerative disease progression: is the vehicle as important as the cargo?","volume":"14","author":"Estes","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111282_bb0075","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111282_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JPD-171103","article-title":"The role of lipids interacting with \u03b1-Synuclein in the pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Galvagnion","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"26","key":"10.1016\/j.pnpbp.2025.111282_bb0085","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.1601899113","article-title":"Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of \u03b1-synuclein","volume":"113","author":"Galvagnion","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111282_bb0090","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/mds.28396","article-title":"The role of cholesterol in \u03b1-Synuclein and Lewy body pathology in GBA1 Parkinson\u2019s disease","volume":"36","author":"Garc\u00eda-Sanz","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pnpbp.2025.111282_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105215","article-title":"Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues","volume":"163","author":"Gliozzi","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111282_bb0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides","volume":"377","author":"Graham","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111282_bb0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","article-title":"Statins and the vascular endothelial inflammatory response","volume":"28","author":"Greenwood","year":"2007","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41467-021-27850-z","article-title":"A genome-wide association study of serum proteins reveals shared loci with common diseases","volume":"13","author":"Gudjonsson","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0120","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4103\/NRR.NRR-D-23-01462","article-title":"Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage","volume":"20","author":"Huang","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"20","key":"10.1016\/j.pnpbp.2025.111282_bb0125","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.jacc.2012.07.045","article-title":"Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects","volume":"60","author":"Johannsen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111282_bb0130","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/brain\/awab402","article-title":"Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups","volume":"145","author":"Kaivola","year":"2022","journal-title":"Brain"},{"issue":"9A","key":"10.1016\/j.pnpbp.2025.111282_bb0135","article-title":"Pharmacogenomics of statin responsiveness","volume":"96","author":"Kajinami","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13195-023-01342-2","article-title":"Distinct effects of cholesterol profile components on amyloid and vascular burdens","volume":"15","author":"Kang","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"8006","key":"10.1016\/j.pnpbp.2025.111282_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.pnpbp.2025.111282_bb0150","first-page":"2996","article-title":"ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia","volume":"36","author":"Kastelein","year":"2015","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111282_bb0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14656566.2018.1428560","article-title":"Improvement of endothelial function by pitavastatin: a meta-analysis","volume":"19","author":"Katsiki","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111282_bb0160","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrendo.2017.119","article-title":"Angiopoietin-like 3 in lipoprotein metabolism","volume":"13","author":"Kersten","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0165","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.3390\/ijms16047890","article-title":"APOE polymorphisms contribute to reduced atorvastatin response in Chilean Amerindian subjects","volume":"16","author":"Lagos","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jamaneurol.2021.5578","article-title":"Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention: a Meta-analysis of randomized clinical trials","volume":"79","author":"Lee","year":"2022","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111282_bb0175","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/qjmed\/hcz189","article-title":"The outcomes of statin therapy in patients with acute ischemic stroke in Taiwan: a nationwide epidemiologic study","volume":"112","author":"Lin","year":"2019","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12944-024-02032-0","article-title":"Elevated serum LDL-C increases the risk of Lewy body dementia: a two-sample mendelian randomization study","volume":"23","author":"Liu","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0190","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI87364","article-title":"Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects","volume":"126","author":"Millar","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111282_bb0195","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/genetics\/163.3.1153","article-title":"Maximum-likelihood estimation of relatedness","volume":"163","author":"Milligan","year":"2003","journal-title":"Genetics"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gepi.22522","article-title":"Bias correction for inverse variance weighting Mendelian randomization","volume":"47","author":"Mounier","year":"2023","journal-title":"Genet. Epidemiol."},{"issue":"23","key":"10.1016\/j.pnpbp.2025.111282_bb0205","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111282_bb0210","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41440-023-01271-5","article-title":"Longitudinal association of hypertension and dyslipidemia with cognitive function in community-dwelling older adults: the SONIC study","volume":"46","author":"Nakamura","year":"2023","journal-title":"Hypertens. Res."},{"issue":"19","key":"10.1016\/j.pnpbp.2025.111282_bb0215","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2011.1649","article-title":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","volume":"306","author":"Nicholls","year":"2011","journal-title":"JAMA"},{"issue":"Pt 4","key":"10.1016\/j.pnpbp.2025.111282_bb0220","first-page":"1093","article-title":"Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0225","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13195-023-01360-0","article-title":"Statins and cognitive decline in patients with Alzheimer\u2019s and mixed dementia: a longitudinal registry-based cohort study","volume":"15","author":"Petek","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111282_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jalz.2017.07.757","article-title":"Association of midlife lipids with 20-year cognitive change: a cohort study","volume":"14","author":"Power","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111282_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017504","article-title":"Mortality in dementia with Lewy bodies compared with Alzheimer\u2019s dementia: a retrospective naturalistic cohort study","volume":"7","author":"Price","year":"2017","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111282_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001547","article-title":"Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation","volume":"20","author":"Richardson","year":"2022","journal-title":"PLoS Biol."},{"issue":"24","key":"10.1016\/j.pnpbp.2025.111282_bb0245","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa2031049","article-title":"Evinacumab in patients with refractory hypercholesterolemia","volume":"383","author":"Rosenson","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111282_bb0250","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2022.05.041","article-title":"Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function","volume":"80","author":"Rosoff","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","article-title":"Alpha-synuclein, lipids and Parkinson\u2019s disease","volume":"49","author":"Ruip\u00e9rez","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.pnpbp.2025.111282_bb0260","series-title":"Multivariable Mendelian Randomization and Mediation","volume":"vol. 11(2)","author":"Sanderson","year":"2021"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0265","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0270","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"issue":"16","key":"10.1016\/j.pnpbp.2025.111282_bb0275","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.2008.03308.x","article-title":"Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials","volume":"67","author":"Smeeth","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0285","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.pnpbp.2025.111282_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101088","article-title":"Statin treatment, oxidative stress and inflammation in a Danish population","volume":"21","author":"S\u00f8rensen","year":"2019","journal-title":"Redox Biol."},{"issue":"25 Pt B","key":"10.1016\/j.pnpbp.2025.111282_bb0295","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111282_bb0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40120-019-00154-7","article-title":"Burden of disease and current Management of Dementia with Lewy bodies: a literature review","volume":"8","author":"Tahami Monfared","year":"2019","journal-title":"Neurol. Ther."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0305","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neurobiolaging.2007.08.005","article-title":"Total cholesterol and oxysterols: early markers for cognitive decline in elderly?","volume":"30","author":"van den Kommer","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111282_bb0310","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"issue":"10004","key":"10.1016\/j.pnpbp.2025.111282_bb0315","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111282_bb0320","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1194\/jlr.M054882","article-title":"Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111282_bb0325","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/jnnp-2021-328164","article-title":"LDL cholesterol is associated with higher AD neuropathology burden independent of APOE","volume":"93","author":"Wingo","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111282_bb0330","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","article-title":"Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111282_bb0335","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111282_bb0340","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat. Genet."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:17:10Z","timestamp":1748528230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":68,"alternative-id":["S0278584625000363"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111282","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic insights of lipid metabolism and lipid-lowering drugs with Lewy body dementia risk: Evidence from Mendelian randomization","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111282"}}